X
20
Cipla Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Carvedilol, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2005-124 - Rev 03
This Chemical Type CEP, issued on March 09, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1745 associated with this CEP further emphasizes